Children and SARS-CoV-2
- PMID: 34265242
- PMCID: PMC8279573
- DOI: 10.1016/j.chom.2021.06.015
Children and SARS-CoV-2
Abstract
A previously immune-naive world population is experiencing natural infection with SARS-CoV-2. Severe COVID-19 predominantly impacts adults, yet multisystem inflammatory disorder primarily impacts children. Herein, we discuss known clinical and biological features of SARS-CoV-2 in children and reflect on currently identified immune features and discuss what remains unknown.
Copyright © 2021 Elsevier Inc. All rights reserved.
References
-
- Castagnoli R., Votto M., Licari A., Brambilla I., Bruno R., Perlini S., Rovida F., Baldanti F., Marseglia G.L. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatr. 2020;174:882–889. - PubMed
-
- Cotugno N., Ruggiero A., Bonfante F., Petrara M.R., Zicari S., Pascucci G.R., Zangari P., De Ioris M.A., Santilli V., Manno E.C., et al. CACTUS Study Team Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies. Cell Rep. 2021;34:108852. - PMC - PubMed
-
- COVID-NET: COVID-19-Associated Hospitalization Surveillance Network, Centers for Disease Control and Prevention. https://gis.cdc.gov/grasp/covidnet/COVID19_5.html. Accessed on April 23, 2021.
-
- Docherty A.B., Harrison E.M., Green C.A., Hardwick H.E., Pius R., Norman L., Holden K.A., Read J.M., Dondelinger F., Carson G., et al. ISARIC4C investigators Features of 20c133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985. - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
